Report cover image

Global Teriparatide Injection Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 199 Pages
SKU # APRC20360164

Description

Summary

According to APO Research, the global Teriparatide Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Teriparatide Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Teriparatide Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Teriparatide Injection market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Teriparatide Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Teriparatide Injection market include Shenzhen Salubris Pharmaceuticals Co., Ltd., Shanghai United Cell Biotechnology Co., Ltd., Pfenex Inc., Eli Lilly and Company and Alvogen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Teriparatide Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Teriparatide Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Teriparatide Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Teriparatide Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Teriparatide Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Teriparatide Injection sales, projected growth trends, production technology, application and end-user industry.

Teriparatide Injection Segment by Company

Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shanghai United Cell Biotechnology Co., Ltd.
Pfenex Inc.
Eli Lilly and Company
Alvogen
Teriparatide Injection Segment by Type

2.5ML
3.0ML
Teriparatide Injection Segment by Application

Hospital
Clinic
Others
Teriparatide Injection Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Teriparatide Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Teriparatide Injection market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Teriparatide Injection significant trends, drivers, influence factors in global and regions.
6. To analyze Teriparatide Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriparatide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Teriparatide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriparatide Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Teriparatide Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Teriparatide Injection industry.
Chapter 3: Detailed analysis of Teriparatide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Teriparatide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Teriparatide Injection in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Teriparatide Injection Sales Value (2020-2031)
1.2.2 Global Teriparatide Injection Sales Volume (2020-2031)
1.2.3 Global Teriparatide Injection Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Teriparatide Injection Market Dynamics
2.1 Teriparatide Injection Industry Trends
2.2 Teriparatide Injection Industry Drivers
2.3 Teriparatide Injection Industry Opportunities and Challenges
2.4 Teriparatide Injection Industry Restraints
3 Teriparatide Injection Market by Company
3.1 Global Teriparatide Injection Company Revenue Ranking in 2024
3.2 Global Teriparatide Injection Revenue by Company (2020-2025)
3.3 Global Teriparatide Injection Sales Volume by Company (2020-2025)
3.4 Global Teriparatide Injection Average Price by Company (2020-2025)
3.5 Global Teriparatide Injection Company Ranking (2023-2025)
3.6 Global Teriparatide Injection Company Manufacturing Base and Headquarters
3.7 Global Teriparatide Injection Company Product Type and Application
3.8 Global Teriparatide Injection Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Teriparatide Injection Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Teriparatide Injection Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Teriparatide Injection Market by Type
4.1 Teriparatide Injection Type Introduction
4.1.1 2.5ML
4.1.2 3.0ML
4.2 Global Teriparatide Injection Sales Volume by Type
4.2.1 Global Teriparatide Injection Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Teriparatide Injection Sales Volume by Type (2020-2031)
4.2.3 Global Teriparatide Injection Sales Volume Share by Type (2020-2031)
4.3 Global Teriparatide Injection Sales Value by Type
4.3.1 Global Teriparatide Injection Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Teriparatide Injection Sales Value by Type (2020-2031)
4.3.3 Global Teriparatide Injection Sales Value Share by Type (2020-2031)
5 Teriparatide Injection Market by Application
5.1 Teriparatide Injection Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Teriparatide Injection Sales Volume by Application
5.2.1 Global Teriparatide Injection Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Teriparatide Injection Sales Volume by Application (2020-2031)
5.2.3 Global Teriparatide Injection Sales Volume Share by Application (2020-2031)
5.3 Global Teriparatide Injection Sales Value by Application
5.3.1 Global Teriparatide Injection Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Teriparatide Injection Sales Value by Application (2020-2031)
5.3.3 Global Teriparatide Injection Sales Value Share by Application (2020-2031)
6 Teriparatide Injection Regional Sales and Value Analysis
6.1 Global Teriparatide Injection Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Teriparatide Injection Sales by Region (2020-2031)
6.2.1 Global Teriparatide Injection Sales by Region: 2020-2025
6.2.2 Global Teriparatide Injection Sales by Region (2026-2031)
6.3 Global Teriparatide Injection Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Teriparatide Injection Sales Value by Region (2020-2031)
6.4.1 Global Teriparatide Injection Sales Value by Region: 2020-2025
6.4.2 Global Teriparatide Injection Sales Value by Region (2026-2031)
6.5 Global Teriparatide Injection Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Teriparatide Injection Sales Value (2020-2031)
6.6.2 North America Teriparatide Injection Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Teriparatide Injection Sales Value (2020-2031)
6.7.2 Europe Teriparatide Injection Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Teriparatide Injection Sales Value (2020-2031)
6.8.2 Asia-Pacific Teriparatide Injection Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Teriparatide Injection Sales Value (2020-2031)
6.9.2 South America Teriparatide Injection Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Teriparatide Injection Sales Value (2020-2031)
6.10.2 Middle East & Africa Teriparatide Injection Sales Value Share by Country, 2024 VS 2031
7 Teriparatide Injection Country-level Sales and Value Analysis
7.1 Global Teriparatide Injection Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Teriparatide Injection Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Teriparatide Injection Sales by Country (2020-2031)
7.3.1 Global Teriparatide Injection Sales by Country (2020-2025)
7.3.2 Global Teriparatide Injection Sales by Country (2026-2031)
7.4 Global Teriparatide Injection Sales Value by Country (2020-2031)
7.4.1 Global Teriparatide Injection Sales Value by Country (2020-2025)
7.4.2 Global Teriparatide Injection Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.5.2 USA Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.6.2 Canada Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.8.2 Germany Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.9.2 France Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.9.3 France Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.11.2 Italy Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.12.2 Spain Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.13.2 Russia Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.16.2 China Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.16.3 China Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.17.2 Japan Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.19.2 India Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.19.3 India Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.20.2 Australia Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.24.2 Chile Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.26.2 Peru Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.28.2 Israel Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.29.2 UAE Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.31.2 Iran Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Teriparatide Injection Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Teriparatide Injection Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Teriparatide Injection Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Shenzhen Salubris Pharmaceuticals Co., Ltd.
8.1.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Comapny Information
8.1.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Business Overview
8.1.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales, Value and Gross Margin (2020-2025)
8.1.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product Portfolio
8.1.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments
8.2 Shanghai United Cell Biotechnology Co., Ltd.
8.2.1 Shanghai United Cell Biotechnology Co., Ltd. Comapny Information
8.2.2 Shanghai United Cell Biotechnology Co., Ltd. Business Overview
8.2.3 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales, Value and Gross Margin (2020-2025)
8.2.4 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product Portfolio
8.2.5 Shanghai United Cell Biotechnology Co., Ltd. Recent Developments
8.3 Pfenex Inc.
8.3.1 Pfenex Inc. Comapny Information
8.3.2 Pfenex Inc. Business Overview
8.3.3 Pfenex Inc. Teriparatide Injection Sales, Value and Gross Margin (2020-2025)
8.3.4 Pfenex Inc. Teriparatide Injection Product Portfolio
8.3.5 Pfenex Inc. Recent Developments
8.4 Eli Lilly and Company
8.4.1 Eli Lilly and Company Comapny Information
8.4.2 Eli Lilly and Company Business Overview
8.4.3 Eli Lilly and Company Teriparatide Injection Sales, Value and Gross Margin (2020-2025)
8.4.4 Eli Lilly and Company Teriparatide Injection Product Portfolio
8.4.5 Eli Lilly and Company Recent Developments
8.5 Alvogen
8.5.1 Alvogen Comapny Information
8.5.2 Alvogen Business Overview
8.5.3 Alvogen Teriparatide Injection Sales, Value and Gross Margin (2020-2025)
8.5.4 Alvogen Teriparatide Injection Product Portfolio
8.5.5 Alvogen Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Teriparatide Injection Value Chain Analysis
9.1.1 Teriparatide Injection Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Teriparatide Injection Sales Mode & Process
9.2 Teriparatide Injection Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Teriparatide Injection Distributors
9.2.3 Teriparatide Injection Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.